INVERNIZZI PIETRO

Ciardullo, S., Mantovani, A., Morieri, M., Muraca, E., Invernizzi, P., Perseghin, G. (2024). Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence. LIVER INTERNATIONAL [10.1111/liv.15939]. Detail

Balsano, C., Burra, P., Duvoux, C., Alisi, A., Piscaglia, F., Gerussi, A., et al. (2023). Artificial Intelligence and liver: Opportunities and barriers. DIGESTIVE AND LIVER DISEASE, 55(11 (November 2023)), 1455-1461 [10.1016/j.dld.2023.08.048]. Detail

Mulinacci, G., Cristoferi, L., Palermo, A., Lucà, M., Gerussi, A., Invernizzi, P., et al. (2023). Risk stratification in primary sclerosing cholangitis. MINERVA GASTROENTEROLOGY, 69(1), 84-94 [10.23736/S2724-5985.20.02821-4]. Detail

Hirschfield, G., Shiffman, M., Gulamhusein, A., Kowdley, K., Vierling, J., Levy, C., et al. (2023). Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. HEPATOLOGY, 78(2), 397-415 [10.1097/HEP.0000000000000395]. Detail

Massironi, S., Elvevi, A., Gallo, C., Laffusa, A., Tortorella, A., Invernizzi, P. (2023). Exploring the spectrum of incidental gastric polyps in autoimmune gastritis. DIGESTIVE AND LIVER DISEASE, 55(9 (September 2023)), 1201-1207 [10.1016/j.dld.2023.02.008]. Detail